Informations:
Erreur:
ID
14127
Description
Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02328755
Lien
https://clinicaltrials.gov/show/NCT02328755
Mots-clés
Versions (1)
- 30/03/2016 30/03/2016 -
Téléchargé le
30 mars 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Myeloid Leukemia NCT02328755
Eligibility Acute Myeloid Leukemia NCT02328755
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukemia NCT02328755
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
AML
Item
patient must have aml not in remission or at very high risk for hct (hematopoietic cell transplantation) relapse.
boolean
C0153886 (UMLS CUI [1])
induction attempts
Item
for newly diagnosed aml, patients must have achieved two consecutive induction attempts without achieving complete remission
boolean
C1514832 (UMLS CUI [1])
aml relapse
Item
for patients initially in complete remission whose aml relapses > 6 months after preceding remission, one re-induction must be attempted to be eligible
boolean
C2367456 (UMLS CUI [1])
re-induction regimen
Item
for aml patients with early relapse, in whom the preceding remission is shorter than 6 months duration, no re-induction regimen is necessary to be eligible
boolean
C0153886 (UMLS CUI [1])
MYELODYSPLASTIC SYNDROME
Item
patients with antecedent mds (myelodysplastic syndrome) who progress to aml may have therapies rendered during both phases counted towards these requirements.
boolean
C3463824 (UMLS CUI [1])
matched donor
Item
availability of an 8/8 matched donor at a, b, c, and dr loci. mismatch at hla dq are permissible. matched related or unrelated donors are acceptable peripheral blood or bone marrow stem cells are acceptable
boolean
C0150103 (UMLS CUI [1])
age
Item
patients must be ≥ 18 years of age and considered a candidate for hct
boolean
C0001779 (UMLS CUI [1])
karnofsky performance status
Item
karnofsky ≥ 70%
boolean
C0206065 (UMLS CUI [1])
Item
patients must meet acceptable organ function criteria: total bilirubin ≤2.5 mg, ast (aspartate transaminase) and alt (alanine transaminase) <5.0 x institutional upper limit of normal; gfr (glomerular filtration rate) >40 ml/min/1.73 m2 for patients with creatinine levels above institutional normal; lung function tests (dlco, fev1, fvc) > 50%; ejection fraction > 50%
integer
C1254358 (UMLS CUI [1])
Code List
patients must meet acceptable organ function criteria: total bilirubin ≤2.5 mg, ast (aspartate transaminase) and alt (alanine transaminase) <5.0 x institutional upper limit of normal; gfr (glomerular filtration rate) >40 ml/min/1.73 m2 for patients with creatinine levels above institutional normal; lung function tests (dlco, fev1, fvc) > 50%; ejection fraction > 50%
CL Item
total bilirubin ≤2.5 mg (1)
C0201913 (UMLS CUI-1)
CL Item
ast/alt 5.0 x institutional upper limit of normal (2)
C0201913 (UMLS CUI-1)
CL Item
gfr (glomerular filtration rate) >40 (3)
C0017654 (UMLS CUI-1)
CL Item
lung function tests (dlco, fev1, fvc) (4)
C0024119 (UMLS CUI-1)
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
contraception
Item
women and men of child-bearing potential must agree to use adequate contraception
boolean
C0700589 (UMLS CUI [1])
chemotherapy treatment for aml
Item
prior chemotherapy treatment for aml within 21 days from the initiation of hct conditioning
boolean
C3665472 (UMLS CUI [1])
CNS disorder
Item
patients may not have evidence or symptoms of cns disease at the time of enrollment
boolean
C0007682 (UMLS CUI [1])
HIV+, htlv1
Item
hiv or htlv1 / htlv2 (human t-lymphotrophic virus) (seropositivity and/or pcr positivity)
boolean
C0019699 (UMLS CUI [1])
C0020094 (UMLS CUI [2])
C0020094 (UMLS CUI [2])
Less than age 18
Item
patients less than 18 years of age
boolean
C3261299 (UMLS CUI [1])
pregnant
Item
pregnant and nursing mothers are excluded from this study
boolean
neuropsychiatric illness
Item
patients with untreated or uncontrolled neuropsychiatric illness
boolean
C3203509 (UMLS CUI [1])
risk to the patient
Item
any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient
boolean
C0525058 (UMLS CUI [1])
Communicable Diseases
Item
uncontrolled infections
boolean
C0009450 (UMLS CUI [1])